The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of the SECuRE trial has been treated with their first dose of 8 GBq of 67 Cu-SAR-bisPSMA.This follows the recent ...

Serkan Oray from UCB shares why the autoinjector pen format is booming, the importance of a patient-centric design, and how ...

HIGHLIGHTS The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of the SECuRE trial has been treated with their first dose of 8 GBq of ...

Serkan Oray from UCB shares why the autoinjector pen format is booming, the importance of a patient-centric design, and how to get a design concept off the ground.

This innovative tech collaboration addresses emotional, logistical and financial challenges associated with international clinical trial recruitme ...